 |
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
|
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
BASIC SCIENCE |
AstraZeneca, *Safety Assessment and Cardiovascular and Gastrointestinal Discovery, Alderley Park, Macclesfield, Cheshire, United Kingdom; and Department of Nephrology, Leicester General Hospital, Gwendolen Road, Leicester, United Kingdom
Correspondence to Dr. James Sidaway, AstraZeneca, Safety Assessment, 23S37-69, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK. Phone: +44-1625-510221; Fax: +44-1625-513779;
ABSTRACT. Renal proximal tubule cells are responsible for the reabsorption of proteins that are present in the tubular lumen. This occurs by receptor-mediated endocytosis, a process that has a requirement for some GTP-binding proteins. Statins are inhibitors of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase used for the therapeutic reduction of cholesterol-containing plasma lipoproteins. However, they can also reduce intracellular levels of isoprenoid pyrophosphates that are derived from the product of the enzyme, mevalonate, and are required for the prenylation and normal function of GTP-binding proteins. The hypothesis that inhibition of HMG-CoA reductase in renal proximal tubule cells could reduce receptor mediated-endocytosis was therefore tested. Five different statins inhibited the uptake of FITC-labeled albumin by the proximal tubule-derived opossum kidney cell line in a dose-dependent manner and in the absence of cytotoxicity. The reduction in albumin uptake was related to the degree of inhibition of HMG-CoA reductase. Simvastatin (e.g., statin) inhibited receptor-mediated endocytosis of both FITC-albumin and FITC-
2-microglobulin to similar extents but without altering the binding of albumin to the cell surface. The effect on albumin endocytosis was prevented by mevalonate and by the isoprenoid geranylgeranyl pyrophosphate but not by cholesterol. Finally, evidence that the inhibitory effect of statins on endocytosis of proteins may be caused by reduced prenylation and thereby decreased function of one or more GTP-binding proteins is provided. These data establish the possibility in principle that inhibition of HMG-CoA reductase by statins in proximal tubule cells may reduce tubular protein reabsorption. E-mail: james.sidaway@astrazeneca.com
This article has been cited by other articles:
 |
|
 |
|
  A. Verhulst, R. Sayer, M. E. De Broe, P. C. D'Haese, and C. D. A. Brown Human Proximal Tubular Epithelium Actively Secretes but Does Not Retain Rosuvastatin Mol. Pharmacol., October 1, 2008; 74(4): 1084 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Kostapanos, H. J. Milionis, and M. S. Elisaf An Overview of the Extra-Lipid Effects of Rosuvastatin Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2008; 13(3): 157 - 174. [Abstract] [PDF]
|
|
|
|
 |
|
 R. H. Samson The Role of Statin Drugs in the Management of the Peripheral Vascular Patient Vascular and Endovascular Surgery, August 1, 2008; 42(4): 352 - 366. [Abstract] [PDF]
|
|
|
|
 |
|
 J. A. Joles Statins and small GTPases: Koch's postulates and chronic kidney disease Nephrol. Dial. Transplant., February 1, 2008; 23(2): 433 - 438. [Full Text] [PDF]
|
|
|
|
|
|
M. S. Kostapanos, H. J. Milionis, V. G. Saougos, K. G. Lagos, C. Kostara, E. T. Bairaktari, and M. S. Elisaf Dose-Dependent Effect of Rosuvastatin Treatment on Urinary Protein Excretion Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 292 - 297. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Diwakar, A. L. Pearson, P. Colville-Nash, N. J. Brunskill, and M. E. C. Dockrell The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1464 - F1470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Eyre, K. Ioannou, B. D. Grubb, M. A. Saleem, P. W. Mathieson, N. J. Brunskill, E. I. Christensen, and P. S. Topham Statin-sensitive endocytosis of albumin by glomerular podocytes Am J Physiol Renal Physiol, February 1, 2007; 292(2): F674 - F681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Atthobari, A. H. Brantsma, R. T. Gansevoort, S. T. Visser, F. W. Asselbergs, W. H. van Gilst, P. E. de Jong, L. T. W. de Jong-van den Berg, and on behalf of PREVEND study group The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3106 - 3114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Kostapanos, H. J. Milionis, I. Gazi, C. Kostara, E. T. Bairaktari, and M. Elisaf Rosuvastatin Increases {alpha}-1 Microglobulin Urinary Excretion in Patients With Primary Dyslipidemia. J. Clin. Pharmacol., November 1, 2006; 46(11): 1337 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tonelli Do Statins Protect the Kidney by Reducing Proteinuria? Ann Intern Med, July 18, 2006; 145(2): 147 - 149. [Full Text] [PDF]
|
|
|
|
 |
|
 G. D'Amico Statins and Renal Diseases: From Primary Prevention to Renal Replacement Therapy. J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S148 - S152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shibata, M. Nagase, and T. Fujita Fluvastatin Ameliorates Podocyte Injury in Proteinuric Rats via Modulation of Excessive Rho Signaling J. Am. Soc. Nephrol., March 1, 2006; 17(3): 754 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. McKenney Efficacy and safety of rosuvastatin in treatment of dyslipidemia Am. J. Health Syst. Pharm., May 15, 2005; 62(10): 1033 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Verhulst, P. C. D'Haese, and M. E. De Broe Inhibitors of HMG-CoA Reductase Reduce Receptor-mediated Endocytosis in Human Kidney Proximal Tubular Cells J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2249 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Agarwal Statin Induced Proteinuria: Renal Injury or Renoprotection? J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2502 - 2503. [Full Text] [PDF]
|
|
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673
